Skip to main content
. 2015 May 18;10(5):e0127380. doi: 10.1371/journal.pone.0127380

Fig 3. Prediction results of the network-flow model.

Fig 3

A) Contributions of different genetic alterations (mutation and copy number variance) to the MAPK pathway activity; B) Predicted residue b is consistent with the mean drug sensitivities (IC50); C) Pearson correlation coefficients between predicted and real MAPK drug sensitivities; D) Predicted drug effects of 10 MAPK drugs to 13 cancer-related genes.